Furthermore, growing evidence indicates that elevated expression of STC-1 is associated with a poor prognosis in various cancers such as human esophageal squamous cell carcinoma, as well as colorectal, glioma, gastric, and breast cancers (19). Here, STC1 is linked to glioma.